SEI Investments’s Minerva Neurosciences NERV Stock Holding History

SEI Investments’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,998	Closed	-$126K	–	2701
2022 Q2	$126K	Hold	37,998	–	–	﹤0.01%	2540
2022 Q1	$252K	Hold	37,998	–	–	﹤0.01%	2361
2021 Q4	$243K	Hold	37,998	–	–	﹤0.01%	2406
2021 Q3	$529K	Hold	37,998	–	–	﹤0.01%	2059
2021 Q2	$705K	Hold	37,998	–	–	﹤0.01%	1943
2021 Q1	$888K	Buy	37,998 +4,333	+13%	+$108K	﹤0.01%	1805
2020 Q4	$630K	Buy	33,665 +4,518	+16%	+$114K	﹤0.01%	1878
2020 Q3	$742K	Buy	29,147 +10,099	+53%	+$273K	﹤0.01%	1737
2020 Q2	$550K	Buy	+19,048	New	+$1.12M	﹤0.01%	1807

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SEI Investments's NERV Position: Q3 2022 in Review

SEI Investments sold out of Minerva Neurosciences (NERV) in Q3 2022, closing a stake of 37,998 shares — an estimated $126K sold.

SEI Investments first reported a position in NERV in Q2 2020 and held it in 9 quarters. The position peaked at $888K in Q1 2021. 25 funds tracked by Wall St. Rank hold NERV as of Q3 2022.

SEI Investments reported no remaining Minerva Neurosciences position as of Q3 2022 after selling out during the quarter.
SEI Investments sold 37,998 Minerva Neurosciences shares in Q3 2022, an estimated $126K.
SEI Investments first reported a position in Minerva Neurosciences in Q2 2020 and held it in 9 quarters.
SEI Investments's Minerva Neurosciences position peaked at $888K in Q1 2021.
25 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2022.

Based on SEI Investments's 13F filing for Q3 2022, filed 14 Nov 2022.